AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ishglimet 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Ronish Bioceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Ishglimet 1mg/500mg Tablet ER

Glimepiride/Metformin extended-release tablets (1mg/500mg) are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive treatment plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is a potential consequence for some patients. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac issues should inform their physician prior to commencement. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Ishglimet 1mg/500mg Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Ishglimet 1mg/500mg Tablet ER

Managing Type 2 diabetes

Major Benefits of Ishglimet 1mg/500mg Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; do not chew, crush, or fracture it. The Ishglimet 1mg/500mg Extended-Release tablet should be administered with a meal.

Common Side effects of Ishglimet 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Ishglimet 1mg/500mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Ishglimet 1mg/500mg Extended-Release tablet should be taken with a meal.

How Ishglimet 1mg/500mg Tablet ER works:

Ishglimet ER tablets (1mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Ishglimet 1mg/500mg Extended-Release tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Ishglimet 1mg/500mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. Prescribing will depend on a physician's assessment of risks versus benefits. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Ishglimet 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ishglimet 1mg/500mg Extended-Release tablets cautiously, potentially requiring dose modification. Consult a physician. Ishglimet 1mg/500mg Extended-Release tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

For individuals with liver impairment, the extended-release Ishglimet 1mg/500mg tablet requires careful administration. Dosage modification of Ishglimet 1mg/500mg ER may be necessary. Physician consultation is advised. In patients experiencing mild to moderate liver disease, initiation of Ishglimet 1mg/500mg ER therapy typically begins with a low dose; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Ishglimet 1mg/500mg Tablet ER :

Should you forget to take your Ishglimet 1mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ishglimet 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Ishglimet 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Ishglimet 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Ishglimet 1mg/500mg Tablet ER and seek immediate medical attention.
Ishglimet 1mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Ishglimet 1mg/500mg ER tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Ishglimet 1mg/500mg ER tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Yes, Ishglimet 1mg/500mg ER tablets can lower blood sugar (cause hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Ishglimet 1mg/500mg ER tablets with alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Ishglimet 1mg/500mg Table...
34
MRP 41
17% off